Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
3.250
+0.010 (0.31%)
Sep 18, 2026, 4:00 PM EDT - Market closed
Altimmune Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +515.38% | Aug 17, 2026 |
| Barclays | Barclays | Buy Maintains $20 | Buy | Maintains | $20 | +515.38% | Aug 13, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $28 | Buy | Maintains | $28 | +761.54% | Aug 13, 2026 |
| William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 12, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 29, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $10 | Buy | Maintains | $10 | +207.69% | Jul 28, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $14 → $11 | Buy | Maintains | $14 → $11 | +238.46% | May 14, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Upgrades $1 → $2.5 | Hold | Upgrades | $1 → $2.5 | -23.08% | Apr 24, 2026 |